TFIIB Monoclonal Antibody

This gene encodes the general transcription factor IIB, one of the ubiquitous factors required for transcription initiation by RNA polymerase II. The protein localizes to the nucleus where it forms a complex (the DAB complex) with transcription factors IID and IIA. Transcription factor IIB serves as a bridge between IID, the factor which initially recognizes the promoter sequence, and RNA polymerase II.

Introducing the TFIIB Monoclonal Antibody, a cutting-edge scientific tool designed to revolutionize research in the field of transcription initiation. This highly specific antibody is meticulously engineered to target and bind to the TFIIB protein, a crucial component of the transcription preinitiation complex.

With its exceptional affinity and selectivity, the TFIIB Monoclonal Antibody enables researchers to accurately detect and quantify TFIIB protein levels in various biological samples. Its unparalleled sensitivity ensures reliable and reproducible results, facilitating a deeper understanding of transcriptional regulation mechanisms.

Crafted with utmost precision, this antibody undergoes rigorous quality control measures to guarantee optimal performance and consistency. Its robust formulation ensures long-term stability, allowing for extended usage without compromising its efficacy.

The TFIIB Monoclonal Antibody is compatible with a wide range of applications, including Western blotting, immunoprecipitation, and immunofluorescence. Its versatility empowers researchers to explore diverse experimental approaches, thereby expanding the horizons of transcriptional research.

Furthermore, this antibody is manufactured in compliance with the highest industry standards, ensuring its reliability and reproducibility across laboratories. Its user-friendly format simplifies experimental procedures, saving valuable time and resources.

In summary, the TFIIB Monoclonal Antibody represents a breakthrough in transcription research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to elevate scientific investigations and pave the way for groundbreaking discoveries in the intricate realm of transcription initiation.